3M Announces $7.4 Billion Settlement in ‘Forever Chemicals’ Injuries Case
3M has committed approximately $7.4 billion to resolve legal claims regarding personal injuries linked to 'forever chemicals' used in firefighting foams.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
According to reports from the Wall Street Journal and Bloomberg, the company has committed nearly $7.4 billion to settle these claims. Seeking Alpha further specifies the commitment amount as $7.35 billion to address PFAS-related litigation. This legal resolution aims to settle claims involving the so-called 'forever chemicals' that have been the subject of extensive litigation involving the manufacturer. Multiple news outlets are tracking the financial implications of this agreement. The Wall Street Journal and Bloomberg both highlight the nearly $7.4 billion figure, while the Star Tribune reports on the $7 billion settlement specifically concerning firefighting foam cases.
PR Newswire has characterized the move as a broad resolution of AFFF personal injury litigation. These reports emphasize the scale of the financial commitment required by 3M to address the legal challenges stemming from the use and presence of per- and polyfluoroalkyl substances, commonly referred to as PFAS. To understand the context of this trend, it is necessary to recognize that PFAS are referred to as 'forever chemicals' due to their persistence in the environment and the human body. The litigation focused on AFFF, a specific type of firefighting foam used for suppressing flammable liquid fires. The legal disputes centered on personal injury claims, where plaintiffs alleged that exposure to these chemicals led to health complications.
This settlement represents a significant effort by 3M to resolve long-standing legal liabilities associated with the production and distribution of these chemical agents. Future developments will likely center on the execution of the settlement terms and the distribution of the committed funds. According to the reported figures, the total amount will range between $7.35 billion and $7.4 billion depending on the source. Observers will be monitoring the NYSE where 3M is traded under the ticker MMM, as reported by Seeking Alpha. The company will now move forward with the broad resolution of the AFFF personal injury litigation to close these specific legal chapters regarding PFAS-related claims.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (94% supported) Updated 2h ago.
Quick answers
How much is 3M paying to settle the PFAS claims?
Reports vary slightly, with the Wall Street Journal and Bloomberg stating nearly $7.4 billion, and Seeking Alpha specifying $7.35 billion.
What specific product is at the center of this litigation?
The litigation involves Aqueous Film-Forming Foam, also known as AFFF, which is used in firefighting.
What are 'forever chemicals' in the context of this case?
They refer to PFAS (per- and polyfluoroalkyl substances), which are the subject of the personal injury claims against 3M.
Coverage (8)
- Baron & Budd and Douglas & London Obtain $7.350 Billion Settlement With 3M Company to Resolve PFAS Personal Injury Lawsuits Business Wire · 3h ago
- 3M commits $7.35 billion to settle 'forever chemicals'-related claims Reuters · 3h ago
- MMM Stock Rises Overnight: Post-It Maker 3M Agrees To $7.4B Chemical Injury Settlement Covering Up To 120,000 Plaintiffs Yahoo Finance · 3h ago
- 3M Reaches Broad Resolution of AFFF Personal Injury Litigation PR Newswire · 3h ago
- 3M commits $7.35B to settle PFAS-related litigation (MMM:NYSE) Seeking Alpha · 3h ago
- 3M strikes $7B settlement in ‘forever chemical’ firefighting foam cases Star Tribune · 3h ago
- 3M Commits Nearly $7.4 Billion to Settle PFAS-Related Claims Bloomberg.com · 3h ago
- 3M Announces $7.4 Billion Settlement in ‘Forever Chemicals’ Injuries Case WSJ · 3h ago
Topics
Related trends
Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has finalized a $40 billion acquisition of Kenvue, the maker of Tylenol, creating a global leader in consumer health and wellness.
Salesforce agrees to buy Cresta (CRM:NYSE)
Salesforce has entered into a definitive agreement to acquire the startup Cresta for $2.7 billion, marking its third acquisition in just two weeks.
Chipotle earnings miss estimates, but same-store sales increase for third straight quarter
Chipotle shares rise and sales climb in the third quarter despite missing overarching earnings estimates.
Where Will Oracle Stock Be in 1 Year?
Oracle stock pops 12 percent following a long-term revenue forecast and analyst day guidance released by the company.
NYSE moves to bring all-or-nothing options to stocks and company earnings
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
GM Is Leaving NYSE for the Nasdaq After More Than 100 Years
General Motors is shifting its stock listing from the New York Stock Exchange to the Nasdaq after more than one hundred years.